# A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer

> **NCT01317069** · PHASE2 · UNKNOWN · sponsor: **Simcere Pharmaceutical Co., Ltd** · enrollment: 100 (estimated)

## Conditions studied

- Gallbladder Cancer
- Bile Duct Cancer

## Interventions

- **DRUG:** Fluorouracil implant

## Key facts

- **NCT ID:** NCT01317069
- **Lead sponsor:** Simcere Pharmaceutical Co., Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01317069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01317069, "A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01317069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*